Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

20/20 Biolabs Inc. (AIDX) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	2.05M
Net Income	-3.74M
Cost of Goods Sold	1.44M
Gross Profit	0.60M
Operating Expenses	5.38M
Operating Income	-3.33M
Non-Operating Income/Expense	-0.41M
Pre-Tax Income	-3.74M
Normalized Pre-Tax Income	-3.74M
Income after Taxes	-3.74M
Income from Continuous Operations	-3.74M
Consolidated Net Income/Loss	-3.74M
Normalized Income after Taxes	-3.74M
EBIT	-3.33M
EBITDA	-3.14M
Weighted-Average Shares Outstanding (Basic)	4.93M
Weighted-Average Shares Outstanding (Diluted)	4.93M
Earnings per Share (EPS) (Basic)	-0.76
Earnings per Share (EPS) (Diluted)	-0.76
Balance Sheet Financials
Current Assets	1.47M
Property, Plant, and Equipment	0.06M
Long-Term Assets	2.67M
Total Assets	4.14M
Current Liabilities	2.46M
Long-Term Debt	0.62M
Long-Term Liabilities	1.69M
Total Liabilities	4.16M
Common Equity	-0.07M
Tangible Shareholders Equity	-1.10M
Shareholders Equity	-0.02M
Common Shares Outstanding	5.44M
Cash Flow Statement Financials
Cash Flow from Operating Activities	-1.92M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	1.16M
Beginning Cash	1.78M
End Cash	1.03M
Increase/Decrease in Cash	-0.76M
Stock-Based Compensation	0.52M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.60
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.03
Debt to Equity Ratio	-36.10
Gross Margin	29.56%
Operating Margin	-162.87%
EBIT Margin	-162.87%
EBITDA Margin	-153.42%
Pre-Tax Profit Margin	-182.82%
Profit Margin	-182.82%
Free Cash Flow	-1.92M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.49
Inventory Turnover	12.40
Receiveable Turnover	10.23
Days Sales in Receivables	35.69
Return on Equity	5630.55%
Return on Tangible Equity	340.54%
Return on Assets	-90.37%
Return on Investments	-623.00%
Book Value Per Share	-0.00
Free Cash Flow per Share	-0.39
Operating Cash Flow per Share	-0.39

Data from Zacks Investment Research, Inc.